TOP2A and hepatocellular carcinoma: In addition, the mutation rate of TOP2A in HCC patients was 1.3%, and amplification was the most common TOP2A mutation type in HCC, and mutations of TOP2A gene may also significantly affect the prognosis of HCC patients.